September 11, 2007
A material developed at Virginia Commonwealth University to stop heaving bleeding in wounded soldiers has been given the green light from the FDA.
The FDA has approved WoundStat for use on humans and commercial
sale. When the material is applied with pressure to a hemorrhaging wound, the material forms a seal to stop rapid blood loss. Tests show the substance stopped lethal hemorrhaging within two minutes.
Bethesda, Maryland-based TraumaCure plans to start offering WoundStat to U.S. military forces by late fall, followed by first responders such as firefighters and emergency medical technicians.